Zhu 2024 — Ecnoglutide Phase 2 in Type 2 Diabetes

The Lancet Diabetes & Endocrinology

Dapeng Zhu, et al.

Summary

Ecnoglutide improved glycemic control and body weight in adults with type 2 diabetes in a phase 2 trial.

Study Details

Study Design

Phase 2 randomized double-blind placebo-controlled trial

Indication

Type 2 diabetes

Intervention

Once-weekly ecnoglutide vs placebo

Species

Human

Sample Size

145 subjects

Risk of Bias Assessment

Sponsor-funded phase 2